These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33031512)

  • 21. Effectiveness of a low-intensity telephone counselling intervention on an untreated metabolic syndrome detected by national population screening in Korea: a non-randomised study using regression discontinuity design.
    Yi SW; Shin SA; Lee YJ
    BMJ Open; 2015 Jul; 5(7):e007603. PubMed ID: 26163030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body Weight Variability and Risk of Cardiovascular Outcomes and Death in the Context of Weight Loss Intervention Among Patients With Type 2 Diabetes.
    Kaze AD; Santhanam P; Erqou S; Ahima RS; Bertoni AG; Echouffo-Tcheugui JB
    JAMA Netw Open; 2022 Feb; 5(2):e220055. PubMed ID: 35179583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and treatment of obesity with lifestyle interventions: review and meta-analysis.
    Galani C; Schneider H
    Int J Public Health; 2007; 52(6):348-59. PubMed ID: 18368998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of an occupational health guideline on employees' body weight-related outcomes, cardiovascular disease risk factors, and quality of life: results from a randomized controlled trial.
    Verweij LM; Proper KI; Weel AN; Hulshof CT; van Mechelen W
    Scand J Work Environ Health; 2013 May; 39(3):284-94. PubMed ID: 23288297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
    Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
    Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS).
    Han TS; Correa E; Lean ME; Lee DM; O'Neill TW; Bartfai G; Forti G; Giwercman A; Kula K; Pendleton N; Punab M; Rutter MK; Vanderschueren D; Huhtaniemi IT; Wu FC; Casanueva FF;
    Endocrine; 2017 Feb; 55(2):456-469. PubMed ID: 27734258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing the effectiveness of the Diabetes Prevention Program through if-then plans: study protocol for the randomized controlled trial of the McGill CHIP Healthy Weight Program.
    Knäuper B; Ivanova E; Xu Z; Chamandy M; Lowensteyn I; Joseph L; Luszczynska A; Grover S
    BMC Public Health; 2014 May; 14():470. PubMed ID: 24885388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference.
    Florath I; Brandt S; Weck MN; Moss A; Gottmann P; Rothenbacher D; Wabitsch M; Brenner H
    Nutr Metab Cardiovasc Dis; 2014 Oct; 24(10):1112-9. PubMed ID: 24932537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.
    Chen L; Peeters A; Magliano DJ; Shaw JE; Welborn TA; Wolfe R; Zimmet PZ; Tonkin AM
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):740-5. PubMed ID: 18043293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular Disease Risk Factors After an Employer-Based Risk Reduction Program: An Observational Cohort Study.
    Holben DH; Rambo C; Howe C; Murray DH; Shubrook JH
    J Am Osteopath Assoc; 2017 Jul; 117(7):425-432. PubMed ID: 28662555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype.
    Cho SW; Kang JY; Park YK; Paek YM; Choi TI
    Nutr Res; 2009 Aug; 29(8):542-50. PubMed ID: 19761888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.
    ; Gregg EW; Jakicic JM; Blackburn G; Bloomquist P; Bray GA; Clark JM; Coday M; Curtis JM; Egan C; Evans M; Foreyt J; Foster G; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jeffery RW; Johnson KC; Kitabchi AE; Knowler WC; Kriska A; Lang W; Lewis CE; Montez MG; Nathan DM; Neiberg RH; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Redmon B; Regensteiner J; Rejeski J; Ribisl PM; Safford M; Stewart K; Trence D; Wadden TA; Wing RR; Yanovski SZ
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):913-921. PubMed ID: 27595918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study.
    Hu D; Hannah J; Gray RS; Jablonski KA; Henderson JA; Robbins DC; Lee ET; Welty TK; Howard BV
    Obes Res; 2000 Sep; 8(6):411-21. PubMed ID: 11011907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family-centered brief intervention for reducing obesity and cardiovascular disease risk: A randomized controlled trial.
    Duncan S; Goodyear-Smith F; McPhee J; Zinn C; Grøntved A; Schofield G
    Obesity (Silver Spring); 2016 Nov; 24(11):2311-2318. PubMed ID: 27616217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors.
    Eriksson KM; Westborg CJ; Eliasson MC
    Scand J Public Health; 2006; 34(5):453-61. PubMed ID: 16990155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial.
    Goodpaster BH; Delany JP; Otto AD; Kuller L; Vockley J; South-Paul JE; Thomas SB; Brown J; McTigue K; Hames KC; Lang W; Jakicic JM
    JAMA; 2010 Oct; 304(16):1795-802. PubMed ID: 20935337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term effects of intensive intervention on changes in lifestyle in patients with hyperfibrinogenaemia and moderate-high cardiovascular risk].
    Illamola Martin L; Rodríguez Cristobal JJ; Alonso-Villaverde C; Salvador-González B; Moral Pelaez I
    Aten Primaria; 2018; 50(6):325-331. PubMed ID: 28729040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a 30-Month Health-Promoting Program on the Prevalence of Cardiovascular Risk Factors in Patients With First Episode Schizophrenia.
    Søgaard HJ; Højlund M; Elliott A; Viuff AG; Vandborg K; Viuff J; Munk-Jørgensen P; Hjorth P
    Am J Ther; 2020; 27(5):e439-e449. PubMed ID: 30677004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of culture medium with growth, weight and cardiovascular development of IVF children at the age of 9 years.
    Zandstra H; Brentjens LBPM; Spauwen B; Touwslager RNH; Bons JAP; Mulder AL; Smits LJM; van der Hoeven MAHBM; van Golde RJT; Evers JLH; Dumoulin JCM; Van Montfoort APA
    Hum Reprod; 2018 Sep; 33(9):1645-1656. PubMed ID: 30032175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association between lifestyle factors assessed by standard question items of specific health checkup and the incidence of metabolic syndrome and hypertension in community dwellers: A five-year cohort study of National Health Insurance beneficiaries in Habikino City].
    Tsutatani H; Funamoto M; Sugiyama D; Kuwabara K; Miyamatsu N; Watanabe K; Okamura T
    Nihon Koshu Eisei Zasshi; 2017; 64(5):258-269. PubMed ID: 28626153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.